Innovation Research

We're developing better, more intelligent vectors to push science forward

 
 

Our approach to innovation is clear

 

1. Programmable intelligent vectors

Disruptive potential to establish new industry-standard vector platforms

  • Anti-oncogenic safety switches

  • Non-integrating LV for in vivo applications

  • Vectors with tissue-specific and cell-specific tropism

 
 

2. Ligand-modified vectors

Engineering vectors for improved cell targeting, purification and concentration

  • Tissue specific tropism

  • Affinity purification

  • Vector concentration

 

3. Novel manufacturing technologies

Improving manufacturing yields and vector-specific performance

  • Engineered vector backbones for improved safety & efficacy

  • Novel cell line development (LV and gamma-retro) including stable LV producer cell lines

  • Novel media additives and transfection enhancers

 

When developing vectors, we always have de-risking in the back of our minds.
— RUBY QUARTEY-PAPAFIO, BSc, SENIOR SCIENTIST, INNOVATION

 
 

We have several synergistic projects that include serum-free suspension cell lines for stable vector production.
— GLENDA DICKSON, PhD, PRINCIPAL SCIENTIST, INNOVATION